Prometheus Biosciences Inc (RXDX)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-04-07 | 2023-04-05 | PS Planned sale |
Chief Financial Officer Officer |
10,000
-50.5%
108.42USD 1,084,200 |
10,000 -50.5% | 108.42 | USD 1,084,200 | |
| 2023-03-17 | 2023-03-15 | PS Planned sale |
Chairman, President & CEO Executive Director |
25,000
-31.2%
116.14USD 2,903,500 |
25,000 -31.2% | 116.14 | USD 2,903,500 | |
| 2023-03-08 | 2023-03-08 | S Sale |
Cedars Sinai Intellectual Property Co Large shareholder |
865,000
-17.8%
114.59USD 99,120,350 |
865,000 -17.8% | 114.59 | USD 99,120,350 | |
| 2023-03-08 | 2023-03-06 | PS Planned sale |
Chief Financial Officer Officer |
10,000
-50.5%
122.13USD 1,221,300 |
10,000 -50.5% | 122.13 | USD 1,221,300 | |
| 2023-03-03 | 2023-03-03 | PS Planned sale |
Chairman, President & CEO Executive Director |
10,620
-16.1%
125.13USD 1,328,881 |
10,620 -16.1% | 125.13 | USD 1,328,881 | |
| 2023-03-03 | 2023-03-01 | PS Planned sale |
Chairman, President & CEO Executive Director |
700
-1.3%
125.26USD 87,682 |
700 -1.3% | 125.26 | USD 87,682 | |
| 2023-02-17 | 2023-02-17 | PS Planned sale |
Chairman, President & CEO Executive Director |
13,680
-19.9%
125.10USD 1,711,368 |
13,680 -19.9% | 125.10 | USD 1,711,368 | |
| 2023-02-17 | 2023-02-16 | PS Planned sale |
Chairman, President & CEO Executive Director |
25,000
-31.2%
119.87USD 2,996,750 |
25,000 -31.2% | 119.87 | USD 2,996,750 | |
| 2023-02-17 | 2023-02-15 | PS Planned sale |
Chairman, President & CEO Executive Director |
25,000
-31.2%
119.42USD 2,985,500 |
25,000 -31.2% | 119.42 | USD 2,985,500 | |
| 2023-02-17 | 2023-02-15 | PS Planned sale |
Chief Financial Officer Officer |
5,000
-33.8%
119.38USD 596,900 |
5,000 -33.8% | 119.38 | USD 596,900 | |
| 2023-01-19 | 2023-01-17 | PS Planned sale |
Chairman, President & CEO Executive Director |
25,000
-31.2%
118.99USD 2,974,750 |
25,000 -31.2% | 118.99 | USD 2,974,750 | |
| 2023-01-19 | 2023-01-17 | PS Planned sale |
Chief Financial Officer Officer |
5,000
-33.8%
119.00USD 595,000 |
5,000 -33.8% | 119.00 | USD 595,000 | |
| 2021-03-18 | 2021-03-16 | B Purchase |
375,000
+20.3%
19.00USD 7,125,000 |
375,000 +20.3% | 19.00 | USD 7,125,000 | ||
| 2021-03-17 | 2021-03-16 | B Purchase |
Point72 Biotech Private Investments, LLC Former 10% Owner |
800,000
+43.3%
19.00USD 15,200,000 |
800,000 +43.3% | 19.00 | USD 15,200,000 | |
| 2021-03-16 | 2021-03-16 | B Purchase | Large shareholder |
850,000
+34.5%
19.00USD 16,150,000 |
850,000 +34.5% | 19.00 | USD 16,150,000 | |
| 2021-03-16 | 2021-03-16 | B Purchase | Non-Executive Director |
15,000
+inf%
19.00USD 285,000 |
15,000 +inf% | 19.00 | USD 285,000 | |
| 2021-03-16 | 2021-03-16 | B Purchase | Non-Executive Director |
500
+inf%
19.00USD 9,500 |
500 +inf% | 19.00 | USD 9,500 | |
| 2021-03-16 | 2021-03-16 | B Purchase | Large shareholder |
800,000
+inf%
19.00USD 15,200,000 |
800,000 +inf% | 19.00 | USD 15,200,000 | |
| 2021-03-16 | 2021-03-16 | B Purchase |
Chief Operating Officer Officer |
14,000
+inf%
19.00USD 266,000 |
14,000 +inf% | 19.00 | USD 266,000 |